Tramadol and Bronchiolitis - a phase IV clinical study of FDA data

Summary:

Bronchiolitis is reported as a side effect among people who take Tramadol (tramadol hydrochloride), especially for people who are female, 60+ old, also take Aspirin, and have Diabetes.

The phase IV clinical study analyzes which people have Bronchiolitis when taking Tramadol. It is created by eHealthMe based on reports of 229,782 people who have side effects when taking Tramadol from the FDA, and is updated regularly.

What is Tramadol?

Tramadol has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 235,798 Tramadol users. Check the latest studies of Tramadol.

What is Bronchiolitis?

Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs) is found to be associated with 410 drugs and 479 conditions by eHealthMe. Check the latest studies of Bronchiolitis.

On Jul, 18, 2026

229,782 people reported to have side effects when taking Tramadol.
Among them, 35 people (0.02%) have Bronchiolitis.

Among these 35 people:

What is the gender of people who have Bronchiolitis when taking Tramadol? *

female: 69.7 %
male: 30.3 %

What is the age of people who have Bronchiolitis when taking Tramadol? *

What are other drugs people take besides Tramadol? *

What are other side effects people have besides Bronchiolitis? *

Abdominal Pain: 15 people, 42.86%
Joint Pain: 14 people, 40.00%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 14 people, 40.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 14 people, 40.00%
Swallowing Difficulty: 13 people, 37.14%
Cough: 13 people, 37.14%
Fibromyalgia (a long-term condition which causes pain all over the body): 13 people, 37.14%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 13 people, 37.14%
Pain In Extremity: 13 people, 37.14%
Oedema Peripheral (superficial swelling): 13 people, 37.14%

What are the existing conditions these people have? *

Neuralgia (pain in one or more nerves): 5 people, 14.29%
Diabetes: 5 people, 14.29%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 4 people, 11.43%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 11.43%
Osteoporosis (bones weak and more likely to break): 4 people, 11.43%
Constipation: 4 people, 11.43%
Type 2 Diabetes: 4 people, 11.43%
High Blood Pressure: 4 people, 11.43%
Haemorrhage Subcutaneous (bleeding from skin): 4 people, 11.43%
Multiple Myeloma (cancer of the plasma cells): 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Tramadol and have Bronchiolitis?

- Check whether Bronchiolitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tramadol:

Tramadol (235,798 reports)

Bronchiolitis treatments and more:

Bronchiolitis (5,841 reports)

Browse all side effects of Tramadol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchiolitis:

Bronchiolitis (410 drugs)

Browse all the conditions that are associated with Bronchiolitis:

Bronchiolitis (479 conditions)

Related publications that referenced our studies

Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Tramadol) and Tramadol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.